Stocklytics Platform

Income Statement

publish
The Stocklytics Income Statement Screener empowers investors to focus on companies with strong financial fundamentals. Whether you’re interested in growth, profitability, or overall revenue strength, this tool helps you make informed decisions.
name
arrow_downwardRevenue Price $ Change % Change Revenue Growth % Gross Profit Operating Income Net Income EBITDA EPS Diluted
Asset logo for symbol CIFRW
CIFRWCipher Mining
_$2.16$0.04arrow_drop_up2.32%-$76.53M-$20.11M-$25.77M$2.07M0.00AI Analysis
Asset logo for symbol VTYX
VTYXVentyx Biosciences
_$1.78$0.01arrow_drop_up0.84%-_-$207.99M-$192.96M-$166.11M-2.22AI Analysis
Asset logo for symbol MAPS
MAPSWM Technology
_$1.20$0.16arrow_drop_up15.38%-$175.46M-$18.45M-$9.89M$53.82M-0.03AI Analysis
Asset logo for symbol IRON
IRONDisc Medicine
_$59.54$2.07arrow_drop_up3.60%-_-$91.12M-$76.42M-$124.71M-3.95AI Analysis
Asset logo for symbol AMLI
AMLIAMERICAN LITHIUM
_$0.69-$0.02arrow_drop_down3.88%-_-$39.46M-$39.90M-$18.83M-0.11AI Analysis
Asset logo for symbol TCRT
TCRTAlaunos Therapeutics
_$2.11-$0.03arrow_drop_down1.40%-_-$34.26M-$35.14M-$12.57M-327.62AI Analysis
Asset logo for symbol DSGN
DSGNDesign Therapeutics
_$5.47-$0.26arrow_drop_down4.51%-_-$78.19M-$66.86M-$60.22M-0.85AI Analysis
Asset logo for symbol HLF
HLFHerbalife Nutrition Ltd
_$7.72-$0.13arrow_drop_down1.71%-$3.87B$356.40M$142.20M$457.80M0.85AI Analysis
Asset logo for symbol EBS
EBSEmergent BioSolutions
_$8.27-$0.35arrow_drop_down4.06%-$343.90M-$726.40M-$760.50M-$4.80M-11.22AI Analysis
Asset logo for symbol BZH
BZHBeazer Homes USA
_$32.91$0.30arrow_drop_up0.91%arrow_drop_up5.59%$424.29M$143.02M$140.17M$160.74M4.44AI Analysis
Asset logo for symbol KORE
KOREKORE Group Holdings
_$1.83-$0.07arrow_drop_down3.55%arrow_drop_up3.04%$148.04M$9.80M-$167.04M$16.58M-11.63AI Analysis
Asset logo for symbol LOOP
LOOPLoop Industries
_$1.30$0.000.00%-_-$21.21M-$21.08M-$19.11M-0.40AI Analysis
Asset logo for symbol BWA
BWABorgWarner
_$33.13-$1.25arrow_drop_down3.65%-$2.56B$1.16B$702.00M$1.97B4.03AI Analysis
Asset logo for symbol CRDF
CRDFCardiff Oncology
_$2.62$0.03arrow_drop_up1.35%arrow_drop_up26.42%_-$45.41M-$41.44M-$46.00M-0.95AI Analysis
Asset logo for symbol AURA
AURAAura Biosciences
_$8.92-$0.22arrow_drop_down2.46%-_-$84.99M-$76.40M-$91.83M-1.73AI Analysis
Asset logo for symbol LGO
LGOLargo Resources Ltd.
_$2.04$0.10arrow_drop_up5.12%-$11.65M-$16.57M-$30.89M$14.99M-0.76AI Analysis
Asset logo for symbol TITN
TITNTitan Machinery
_$14.00-$0.25arrow_drop_down1.75%arrow_drop_up24.85%$531.35M$168.84M$112.44M$162.00M2.59AI Analysis
Asset logo for symbol HOUR
HOURHour Loop
_$1.56-$0.04arrow_drop_down2.85%arrow_drop_up37.72%$66.51M-$3.00M-$2.42M$2.07M0.04AI Analysis
Asset logo for symbol SUP
SUPSuperior Industries International
_$2.37$0.02arrow_drop_up0.85%-$97.69M-$51.44M-$92.88M$86.51M-3.94AI Analysis
Asset logo for symbol TPIC
TPICTPI Composites
_$2.02-$0.05arrow_drop_down2.42%-_-$163.59M-$201.77M-$117.59M-0.14AI Analysis
Showing 3761-3780 of 4977
Results per page:

Gain deeper insights into a company's earnings with the Stocklytics Income Statement Screener, designed to rank stocks in descending order of revenue. This tool allows you to quickly assess companies with the highest revenue and their overall income performance, providing key financial metrics for smarter investment decisions. Our screener offers detailed insights into the following income statement components: - Revenue Growth – Identify companies with impressive year-over-year growth, a critical indicator of potential future success. - Gross Profit – Analyze how well a company is managing its core production costs to generate profit. - Operating Income – Understand a company’s ability to generate profit from its primary operations, excluding non-operational activities. - Net Income – Examine the company's bottom line after all expenses, providing a clear picture of profitability. - EBITDA – Evaluate a company’s earnings before interest, taxes, depreciation, and amortization to get a sense of its overall profitability and operating performance. - EPS Diluted – Review earnings per share on a diluted basis, reflecting potential impacts of convertible securities and giving you a clearer picture of shareholder returns. By using the Stocklytics Income Statement Screener, you’ll have access to vital financial data that will help you evaluate a company's performance, profitability, and growth potential. Why the Income Statement Matters: - Revenue Performance: Understand which companies are excelling at generating top-line revenue. - Profitability: Analyze margins and earnings to identify financially strong companies. - Earnings Per Share: Evaluate companies with high earnings per share, a key metric for investors.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Take Your Investments to a Whole New Level